deepull unveils 1 hour, direct-from-blood multiplex PCR test for 95% of sepsis-causing pathogens at ESCMID 2024 deepull unveils 1 hour, direct-from-blood multiplex PCR test for 95% of sepsis-causing pathogens at ESCMID 2024 UllCORE is designed to transform life-saving clinical decision making for sepsis...

deepull appoints Kimberle Chapin, MD, as Chief Medical Officer and Wade Stevenson as Chief Marketing and Sales Officer deepull appoints Kimberle Chapin, MD, as Chief Medical Officer and Wade Stevenson as Chief Marketing and Sales Officer Kimberle Chapin brings significant expertise in microbiology and infectious...

Spain: EUR 20 million EIB loan to DeepUll accelerates early detection and diagnosis of Sepsis PRESS RELEASE                                         Luxembourg, 13th December 2022 Spain: EUR 20 million EIB loan to DeepUll accelerates early detection and diagnosis of Sepsis The EIB and...